NEW YORK (GenomeWeb) – NeoGenomics today reported that its fourth quarter revenues increased 36 percent with growth driven by both organic operations and its July 2014 acquisition of PathLogic.

The Ft. Myers, Fla.-based molecular testing clinical lab reported total revenues of $25 million for the three months ended Dec. 31, up from $18.3 million for the fourth quarter of 2013. It beat analysts' consensus estimate of $24.3 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.